Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep Promotion vs. Disruption in High Suicide Risk Inpatients
NCT07010718Phase 1Not yet recruiting
- Sponsor
- UTHealth Houston
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by UTHealth Houston. Primary endpoints: Pittsburgh Sleep Quality Index, Insomnia Severity Index and 1 more. Planned start Jun 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07010718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07010718.